During CEMIP (cell migration-inducing and hyaluronan-binding protein)-mediated CRC metastasis, CEMIP promotes the translocation of β-catenin and reprograms glutamine metabolism by increasing GLS1 and SLC1A5 protein expression [101]. Here, GLS is linked to colorectal carcinoma.